(Q34403823)

English

Meloxicam

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1 reference

Europe PubMed Central

Meloxicam. (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1 reference

ChEBI release 2020-05-28

author name string

S Noble

1

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

J A Balfour

2

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

publication date

1 March 1996

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

51

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

424-30; discussion 431-32

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Influence of meloxicam on furosemide pharmacokinetics and pharmacodynamics in healthy volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/8882380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An open study to assess the safety and tolerability of meloxicam 15 mg in subjects with rheumatic disease and mild renal impairment

1 reference

https://pubmed.ncbi.nlm.nih.gov/8882380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meloxicam: a potent inhibitor of adjuvant arthritis in the Lewis rat

1 reference

https://pubmed.ncbi.nlm.nih.gov/8882380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interaction of meloxicam with cimetidine, Maalox, or aspirin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8882380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The efficacy and tolerability of an 8-day administration of intravenous and oral meloxicam: a comparison with intramuscular and oral diclofenac in patients with acute lumbago. German Meloxicam Ampoule Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8882380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Distribution of [14C]meloxicam in joints of rats with adjuvant arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8882380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and metabolic pattern after intravenous infusion and oral administration to healthy subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/8882380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the onset and intensity of action of intramuscular meloxicam and oral meloxicam in patients with acute sciatica

1 reference

https://pubmed.ncbi.nlm.nih.gov/8882380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of cholestyramine on the pharmacokinetics of meloxicam, a new non-steroidal anti-inflammatory drug (NSAID), in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/8882380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind, randomized trial to compare meloxicam 15 mg with diclofenac 100 mg in the treatment of osteoarthritis of the knee

1 reference

https://pubmed.ncbi.nlm.nih.gov/8882380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A long-term study to evaluate the safety and efficacy of meloxicam therapy in patients with rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8882380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meloxicam in osteoarthritis: a 6-month, double-blind comparison with diclofenac sodium

1 reference

https://pubmed.ncbi.nlm.nih.gov/8882380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of meloxicam on the pharmacokinetics of beta-acetyl-digoxin

1 reference

https://pubmed.ncbi.nlm.nih.gov/8882380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of food on pharmacokinetics of meloxicam, a new non steroidal anti-inflammatory drug (NSAID)

1 reference

https://pubmed.ncbi.nlm.nih.gov/8882380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A six-month double-blind trial to compare the efficacy and safety of meloxicam 7.5 mg daily and naproxen 750 mg daily in patients with rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8882380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tolerability of multiple administration of intramuscular meloxicam: a comparison with intramuscular piroxicam in patients with rheumatoid arthritis or osteoarthritis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8882380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind study to compare the efficacy and safety of meloxicam 15 mg with piroxicam 20 mg in patients with osteoarthritis of the hip.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8882380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacology of meloxicam, a new non-steroidal anti-inflammatory drug with an improved safety profile through preferential inhibition of COX-2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8882380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A 4-week, double-blind, parallel-group study to compare the gastrointestinal effects of meloxicam 7.5 mg, meloxicam 15 mg, piroxicam 20 mg and placebo by means of faecal blood loss, endoscopy and symptom evaluation in healthy volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/8882380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-inflammatory, analgesic, antipyretic and related properties of meloxicam, a new non-steroidal anti-inflammatory agent with favourable gastrointestinal tolerance

1 reference

https://pubmed.ncbi.nlm.nih.gov/8882380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New insights into the mode of action of anti-inflammatory drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/8882380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind, randomized, placebo-controlled study of efficacy and tolerance of meloxicam treatment in patients with osteoarthritis of the knee

1 reference

https://pubmed.ncbi.nlm.nih.gov/8882380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meloxicam: influence on arachidonic acid metabolism. Part II. In vivo findings

1 reference

https://pubmed.ncbi.nlm.nih.gov/8882380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of meloxicam in patients with end-stage renal failure on haemodialysis: a comparison with healthy volunteers.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8882380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00003495-199651030-00007

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34403823&oldid=2196591327"